This graph shows the revenue of Eli Lilly and Company from 2022 to 2024, sorted by segment. Eli Lilly is one of the top global pharmaceutical companies and one of the world's largest manufacturers of psychiatric medications. In 2024, the company generated some *** billion U.S. dollars of revenue through its oncology segment.

In fiscal year 2024, Eli Lilly and Company's revenue by segment (products & services) are as follows: Collaboration and Other Revenue: $4.29 B, Product: $40.75 B.

This graph shows the revenue of Eli Lilly and Company from 2007 to 2024. Eli Lilly is one of the top global pharmaceutical companies. In 2024, the company generated over ** billion U.S. dollars of revenue.

As of early March 2025, Eli Lilly had a market cap of over *** billion U.S. dollars and thus was the leader among big pharma companies based on market capitalization. The massive rise of Eli Lilly's market value, which started in 2023, is based in a large part on its strong pipeline. This statistic depicts the top 10 biotech and pharmaceutical companies worldwide based on market capitalization as of 2025. Biotech and pharmaceutical companiesPharmaceutical companies are best known for manufacturing pharmaceutical drugs. These drugs have the aim to diagnose, to cure, to treat, or to prevent diseases. The pharmaceutical sector represents a huge industry, with the global pharmaceutical market being worth more than *** trillion U.S. dollars. Among the best known top global pharmaceutical players are Pfizer, Merck and Johnson & Johnson from the U.S., Novartis and Roche from Switzerland, Sanofi from France, etc. Most of these companies are involved not only in pure pharmaceutical business, but also manufacture medical technology and consumer health products, vaccines, etc. For example, Johnson & Johnson makes most of its revenues through medical devices, diagnostics and consumer health products. There are both pure play biotechnology companies and pharmaceutical companies which, among other products, also produce biotech products within their biotechnological divisions. Most of the leading global pharmaceutical companies have biopharmaceutical divisions. Although not a pure play biotech firm, Roche from Switzerland is among the leaders by revenues from biotech therapies worldwide. In contrast, California-based company Amgen is the world’s largest pure-play biotech company. Amgen made over ** billion U.S. dollars of revenue in 2024. Biotech companies use biotechnology to generate their products, most often medical drugs or agricultural genetic engineering. The latter segment was dominated by Monsanto, nowadays a part of Bayer CropScience. The United Nations Convention on Biological Diversity defines biotechnology as follows: "Any technological application that uses biological systems, living organisms, or derivatives thereof, to make or modify products or processes for specific use." In fact, biotechnology is thousands of years old, used in agriculture, food manufacturing and medicine.